Skip to main content
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Beta Blockers Best Avoided in COPD Patients Without Cardiovascular Disease

View All News

New research presented at the CHEST annual meeting and published simultaneously in the New England Journal of Medicine showed that treatment with the beta blocker metoprolol failed to increase the time to exacerbation and was associated with more hospitalizations in patients with COPD without established cardiovascular indications for beta-blocker use. Gerard J. Criner, MD, FACP, FACCP, Chair and Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University and Director of the Temple Lung Center, led the Temple Lung Center’s participation in the trial. MedPage Today provided coverage of the study’s results and included comments from Dr. Criner.